The regional pattern of abnormal cerebrovascular reactivity in HIV-infected, virally suppressed women.

Journal Article (Journal Article)

The purpose of this study was to assess whole brain and regional patterns of cerebrovascular reactivity (CVR) abnormalities in HIV-infected women using quantitative whole brain arterial spin labeling (ASL). We hypothesized that HIV-infected women would demonstrate decreased regional brain CVR despite viral suppression. This cross-sectional study recruited subjects from the Bay Area Women's Interagency Health Study (WIHS)-a cohort study designed to investigate the progression of HIV disease in women. In addition to conventional noncontrast cerebral MRI sequences, perfusion imaging was performed before and after the administration of intravenous acetazolamide. CVR was measured by comparing quantitative ASL brain perfusion before and after administration of intravenous acetazolamide. In order to validate and corroborate ASL-based whole brain and regional perfusion, phase-contrast (PC) imaging was also performed through the major neck vessels. FLAIR and susceptibility weighted sequences were performed to assess for white matter injury and microbleeds, respectively. Ten HIV-infected women and seven uninfected, age-matched controls were evaluated. Significant group differences were present in whole brain and regional CVR between HIV-infected and uninfected women. These regional differences were significant in the frontal lobe and basal ganglia. CVR measurements were not significantly impacted by the degree of white matter signal abnormality or presence of microbleeds. Despite complete viral suppression, dysfunction of the neurovascular unit persists in the HIV population. Given the lack of association between CVR and traditional imaging markers of small vessel disease, CVR quantification may provide an early biomarker of pre-morbid vascular disease.

Full Text

Duke Authors

Cited Authors

  • Callen, AL; Dupont, SM; Pyne, J; Talbott, J; Tien, P; Calabrese, E; Saloner, D; Chow, FC; Narvid, J

Published Date

  • October 2020

Published In

Volume / Issue

  • 26 / 5

Start / End Page

  • 734 - 742

PubMed ID

  • 32500476

Pubmed Central ID

  • PMC7895531

Electronic International Standard Serial Number (EISSN)

  • 1538-2443

Digital Object Identifier (DOI)

  • 10.1007/s13365-020-00859-8


  • eng

Conference Location

  • United States